Clinical trialists generally accept the premise that surprising results in subgroups of a randomized, controlled trial most likely arise from chance. As we wrote nearly three decades ago, “We believe ...

At a time when data drives nearly every decision, information isn’t just a resource—it’s a transformative force. The real value of data emerges when it’s analyzed through different lenses, unlocking ...

Even though the Food and Drug Administration (FDA) has approved more than 200 commercial radiology AI products, substantial obstacles must be overcome before we are likely to see widespread successful ...